<SEC-DOCUMENT>0001387131-20-002923-index.html : 20200317
<SEC-HEADER>0001387131-20-002923.hdr.sgml : 20200317
<ACCEPTANCE-DATETIME>20200317090845
ACCESSION NUMBER:		0001387131-20-002923
CONFORMED SUBMISSION TYPE:	SC 13G/A
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		20200317
DATE AS OF CHANGE:		20200317

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Millendo Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001544227
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				451472564
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		SC 13G/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	005-87213
		FILM NUMBER:		20719401

	BUSINESS ADDRESS:	
		STREET 1:		110 MILLER AVENUE, SUITE 100
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104
		BUSINESS PHONE:		734-845-9000

	MAIL ADDRESS:	
		STREET 1:		110 MILLER AVENUE, SUITE 100
		CITY:			ANN ARBOR
		STATE:			MI
		ZIP:			48104

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	OvaScience, Inc.
		DATE OF NAME CHANGE:	20120308

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ROCHE FINANCE LTD
		CENTRAL INDEX KEY:			0001053942
		STATE OF INCORPORATION:			V8

	FILING VALUES:
		FORM TYPE:		SC 13G/A

	BUSINESS ADDRESS:	
		STREET 1:		C/O HOFFMAN LA ROCHE
		STREET 2:		124 GRENSACHERSTRASSE CH 4002
		CITY:			BASEL SWITZERLAND
		STATE:			V8

	MAIL ADDRESS:	
		STREET 1:		C/O HOFFMAN LA ROCHE
		STREET 2:		124 GRENSACHERSTRASSE CH 4002
		CITY:			BASEL SWITZERLAND
		STATE:			V8
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13G/A
<SEQUENCE>1
<FILENAME>mlnd-sc13ga_123119.htm
<DESCRIPTION>AMENDMENT NO. 1 TO FORM SC 13G
<TEXT>
Document 1 - file: mlnd-sc13ga_123119.htm

</DOCUMENT>
</SEC-DOCUMENT>